Epidemiologist Lead
GlaxoSmithKline
Bethesda, United States
Jennifer E. Gerber, PhD, MSc is an Epidemiologist Lead at GSK with expertise in infectious disease preclinical research, post marketing authorization studies, and survey research. She serves as the Chair of the International Society of Pharmacoepidemiology's Vacccine Special Interest Group and is the Course Lead for Intermediate/Advanced Topics in Vaccine Safety and Effectiveness. Through her role at GSK, she contributes to pre and post-licensure COVID-19 and influenza vaccine effectiveness and safety studies. Dr. Gerber is experienced working on COVID-19-related initiatives focused on inclusive participation in clinical trials, addressing pandemic-related misinformation, and evaluating COVID-19 vaccination-related values and intentions. Her skills include planning and conducting data analyses, presenting complex data in written reports, giving oral presentations, and communicating findings to stakeholders.
Disclosure information not submitted.
Intermediate /Advanced Topics in Vaccine Safety and Effectiveness
Thursday, August 24, 2023
2:00 PM – 6:00 PM ADT
